Woodline Partners’s Pardes Biosciences PRDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-238,804
Closed -$2.38M – 829
2021
Q3
$2.38M Buy
238,804
+31,130
+15% +$309K 0.04% 386
2021
Q2
$2.07M Hold
207,674
– – 0.04% 351
2021
Q1
$2.07M Buy
+207,674
New +$2.15M 0.05% 283

Other funds holding PRDS

Woodline Partners's PRDS Position: Q4 2021 in Review

Woodline Partners sold out of Pardes Biosciences (PRDS) in Q4 2021, closing a stake of 238,804 shares — an estimated $2.38M sold.

Woodline Partners first reported a position in PRDS in Q1 2021 and held it in 3 quarters. The position peaked at $2.38M in Q3 2021. 41 funds tracked by Wall St. Rank hold PRDS as of Q4 2021.

  • Woodline Partners reported no remaining Pardes Biosciences position as of Q4 2021 after selling out during the quarter.
  • Woodline Partners sold 238,804 Pardes Biosciences shares in Q4 2021, an estimated $2.38M.
  • Woodline Partners first reported a position in Pardes Biosciences in Q1 2021 and held it in 3 quarters.
  • Woodline Partners's Pardes Biosciences position peaked at $2.38M in Q3 2021.
  • 41 funds tracked by Wall St. Rank held Pardes Biosciences as of Q4 2021.

Based on Woodline Partners's 13F filing for Q4 2021, filed 14 Feb 2022.